Sutaria Saumya's Form 4 filing
Tenet Healthcare Corp (THC) · filed Aug 26, 2026
- Accession no.
- 0001193125-26-369162
- Filed
- Aug 26, 2026, 8:00 PM ET
- Trade date
- Aug 24-25, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $27.6M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sutaria SaumyaCIK 0001760857 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | Common Stock | SSaleDisposed | −13,344 | $278.17F1,F2 | −$3,711,900.48 | 520,220 | Direct | |
| Aug 24, 2026 | Common Stock | SSaleDisposed | −36,656 | $278.90F2,F3 | −$10,223,358.4 | 483,564 | Direct | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −17,220 | $273.34F2,F4 | −$4,706,914.8 | 466,344 | Direct | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −24,881 | $274.10F2,F5 | −$6,819,882.1 | 441,463 | Direct | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −7,899 | $275.26F2,F6 | −$2,174,278.74 | 433,564 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57.
Referenced by the price of 1 transaction in Table I.
- F2
The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Referenced by the price of 5 transactions in Table I.
- F3
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14.
Referenced by the price of 1 transaction in Table I.
- F4
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64.
Referenced by the price of 1 transaction in Table I.
- F5
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64.
Referenced by the price of 1 transaction in Table I.
- F6
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55.
Referenced by the price of 1 transaction in Table I.